Equillium, INC. (EQ) SEC Filings — 2024
19 SEC filings for Equillium, INC. (EQ) in 2024.
Filings
- Equillium Faces NASDAQ Delisting Concerns — 8-K · Dec 13, 2024
- Equillium, Inc. Reports Board and Officer Changes — 8-K · Dec 12, 2024
- Equillium, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Equillium, Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 13, 2024
- Equillium Appoints New Chief Medical Officer — 8-K · Oct 31, 2024
- Equillium, Inc. Files 10-Q for Q2 2024 — 10-Q · Aug 8, 2024
- Equillium Faces NASDAQ Listing Concerns — 8-K · Jul 23, 2024
- Equillium, Inc. Files 8-K on Financial Condition — 8-K · Jul 18, 2024
- Equillium, Inc. Files 8-K for Other Events — 8-K · Jun 4, 2024
- Equillium, Inc. Files 8-K on Security Holder Vote Matters — 8-K · May 23, 2024
- Equillium, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Equillium, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 11, 2024
- Equillium, Inc. Files 8-K — 8-K · Apr 1, 2024
- Equillium, Inc. Files 8-K on Financials — 8-K · Mar 25, 2024
- Equillium, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 25, 2024
- Equillium Appoints New CMO, Adds Director, Renews CEO Contract — 8-K · Mar 8, 2024
- Equillium Files 8-K on Financial Condition and Other Events — 8-K · Feb 23, 2024
- Equillium Files 8-K for 'Other Event' on Feb 21 — 8-K · Feb 22, 2024
- Takeda Pharma Discloses 1.84M Share Stake in Equillium — SC 13G · Jan 19, 2024